Treatment of Hypomagnesaemia with Serum Magnesium 0.40–0.49 mmol/L Without Symptoms, or 0.50–0.70 mmol/L With Symptoms
Two distinct presentations of hypomagnesaemia share the same first-line management pathway: a serum magnesium of 0.40 to 0.49 mmol/L in a patient who is asymptomatic, and a serum magnesium of 0.50 to 0.70 mmol/L in a patient who is symptomatic. Both indicate a need for oral magnesium replacement.
Clinical Scenario
The serum magnesium level and the presence or absence of symptoms together define the appropriate management pathway. Oral magnesium replacement is required when serum magnesium is 0.40 to 0.49 mmol/L and the patient is asymptomatic, or when serum magnesium is 0.50 to 0.70 mmol/L and the patient is symptomatic.
Treatment Approach (Partial Overview)
First-line management involves oral magnesium supplementation. The complete protocol specifies the agent of choice, the dosing schedule, and guidance for patients in whom oral supplementation requires special consideration.
Full regimen, agent details, and clinical decision points available in the structured protocol below.
Treatment Goal
Serum magnesium stable and within the normal therapeutic range (0.70 to 1.0 mmol/L), with therapy reviewed on a weekly basis.
References
- 0.40 to 0.49 and asymptomatic Oral Magnesium required.
- 0.50 to 0.70 and symptomatic Oral Magnesium required.
- Normal Dose: 15 to 24mmol/day in divided doses.
- Magnesium aspartate dihydrate (Magnaspartate®) 10mmol (243mg) per sachet 1 to 2 sachets per day.
- Dissolve the contents of each sachet in 50 to 200mL of water, tea or orange juice and take immediately.
- Oral magnesium supplements are contraindicated in severe renal impairment (eGFR <30mL/min) due to the risk of magnesium accumulation and severe hypermagnesaemia.
- Due to the lack of information in this patient group and the manufacturer's contraindication, treatment should only be prescribed if absolutely necessary, at 50% of the usual dose, with close monitoring, and should be de-prescribed promptly once hypomagnesaemia has resolved.
- Magnesium levels should be monitored, and therapy should be reviewed on a weekly basis. Discontinue treatment if levels are stable and within the normal therapeutic range.
View source ↗